CXCR4/CXCL12 mediate autocrine cell- cycle progression in NF1-associated malignant peripheral nerve sheath tumors.
about
Pancreatic cancer stem cell markers and exosomes - the incentive pushCurrent status and perspectives in atomic force microscopy-based identification of cellular transformationThe association of CXCR4 expression with clinicopathological significance and potential drug target in prostate cancer: a meta-analysis and literature reviewHarnessing the genome for characterization of G-protein coupled receptors in cancer pathogenesisA RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressorA murine model of neurofibromatosis type 2 that accurately phenocopies human schwannoma formationGenome-wide consequences of deleting any single geneExpression of CXCL12 and its receptor CXCR4 in patients with adenomyosis.Tetramethylpyrazine-mediated regulation of CXCR4 in retinoblastoma is sensitive to cell density.MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.TAGLN expression is upregulated in NF1-associated malignant peripheral nerve sheath tumors by hypomethylation in its promoter and subpromoter regions.Genome-wide Twist1 occupancy in endocardial cushion cells, embryonic limb buds, and peripheral nerve sheath tumor cells.The intricate role of CXCR4 in cancer.Characterization of a murine model of metastatic human non-small cell lung cancer and effect of CXCR4 inhibition on the growth of metastasesSDF-1/CXCL12 induces directional cell migration and spontaneous metastasis via a CXCR4/Gαi/mTORC1 axis.Monoallelic loss of the imprinted gene Grb10 promotes tumor formation in irradiated Nf1+/- mice.Downregulation of CXCR4 in Metastasized Breast Cancer Cells and Implication in Their Dormancy.EZH2-mediated loss of miR-622 determines CXCR4 activation in hepatocellular carcinoma.Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy.Inhibition of CXCR4 by LY2624587, a Fully Humanized Anti-CXCR4 Antibody Induces Apoptosis of Hematologic MalignanciesAlpha fetoprotein plays a critical role in promoting metastasis of hepatocellular carcinoma cells.Cannabinoid Receptor-2 Regulates Embryonic Hematopoietic Stem Cell Development via Prostaglandin E2 and P-Selectin Activity.Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation.The Challenge of Cancer Genomics in Rare Nervous System Neoplasms: Malignant Peripheral Nerve Sheath Tumors as a Paradigm for Cross-Species Comparative Oncogenomics.An Arntl2-Driven Secretome Enables Lung Adenocarcinoma Metastatic Self-SufficiencyCanonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenanceIdentification of key genes in glioblastoma-associated stromal cells using bioinformatics analysis.Extending the convergence of canonical WNT signaling and classic cancer pathways for treatment of malignant peripheral nerve sheath tumors.Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors.BET bromodomain inhibition triggers apoptosis of NF1-associated malignant peripheral nerve sheath tumors through Bim inductionSDF-1/CXCR4 axis induces human dental pulp stem cell migration through FAK/PI3K/Akt and GSK3β/β-catenin pathways.CK2 blockade causes MPNST cell apoptosis and promotes degradation of β-cateninPreclinical therapeutic efficacy of a novel pharmacologic inducer of apoptosis in malignant peripheral nerve sheath tumors.The role of nerve microenvironment for neurofibroma development.CXCR7 Participates in CXCL12-mediated Cell Cycle and Proliferation Regulation in Mouse Neural Progenitor Cells.Hepatitis B virus X protein promotes the stem-like properties of OV6+ cancer cells in hepatocellular carcinoma.Advances in the treatment of neurofibromatosis-associated tumours.Obstructive sleep apnea and cancer: effects of intermittent hypoxia?Expression and inhibition of BRD4, EZH2 and TOP2A in neurofibromas and malignant peripheral nerve sheath tumors.Cancer of the Peripheral Nerve in Neurofibromatosis Type 1.
P2860
Q26741215-7BD5917F-0C71-47C7-A423-078CD864B3C7Q26747795-799AC93B-B6EA-4602-910B-FF62F111D3D7Q26785506-3B6DA04A-1CE0-44F7-A18E-93EEFD7417B7Q26861766-FB7BD207-D992-4850-8A8F-57F929E3C86FQ27003534-78D2ACBD-0C11-476B-8538-9A1F53D0BA92Q27301307-D72BB025-C258-41E6-8E71-6D48755DFC5EQ28383348-C766C922-AD3E-4DAE-AC3F-B2EA6B3D3167Q33597520-C481550C-BEFB-4AA5-BED7-D2B217C21155Q33671637-51A74492-1CA4-4BBF-A01E-59AAC06B394CQ34022861-3634F387-05CC-44BB-802B-CBB392544835Q34105259-BE640F6A-6CAF-4CFE-938E-CBFE80ECC327Q34308984-098D4C12-0E3D-4F99-9E71-C57ABDC3918AQ35067624-0DF9FA63-37EC-4BC9-B988-C02F0F3E84AFQ35376170-B2C43B4D-6BC0-4154-A59F-26F0176F969CQ35576488-5AB9B5F6-CBAF-4E3E-92CF-C856062E933FQ35639252-4FAD662E-ACCC-4052-B4E2-7C9400D0A55BQ35666361-2DC173E6-22F8-4FD6-980A-46CE79946356Q35787278-7187E35E-6E29-445C-B6ED-318A012E0AAFQ35836868-143A5F44-C355-4FBE-99CA-0A713CB09620Q35949372-4ED557BC-6CA4-497A-8AF7-4086C7CB6D51Q36595263-C484E930-94C0-42A6-94AC-03D27982C220Q36660540-6992B457-00AF-4C35-9588-DAFFD8D428EAQ36663582-D4B07733-DD50-4105-93A7-A7FB597D1BC5Q36753692-B072E519-4518-45A9-88E5-E9D5142C611BQ36892847-AD81DF3C-12FC-4403-AF82-8EEA03C4D172Q36920489-D25879C9-B023-4C46-B15D-B11B82FBBB7CQ36954204-AC6B8493-B6DA-47DD-BAD6-D5FA25F08EE1Q37221461-CE93FD4E-30C3-4A29-809E-7354A069D3D0Q37359459-B0385AC7-403D-4209-A5DF-7C3421A3F933Q37523017-3B5DD30A-C4CF-4758-8108-248E3F9E6EEAQ37571115-3DC3E242-2D06-4AB0-9490-53D0E9A28BFEQ37619722-C082ACF5-3AE8-4D30-8478-B2B3B2EE79B7Q37625501-685A8DA9-A88B-4073-B916-EC65CB72F7CCQ37641630-65CBE03A-E5F2-4DD2-9F54-5F0B4F53ED4AQ37692715-35159E1F-F3D4-4E74-AE4F-20BB54C541A2Q37744990-DE7A5700-1BD8-4C93-B0A0-1F79F75F32E4Q38128516-421B2004-C7E1-4EB8-82C4-D20EBDF8B7AEQ38631730-579BDB6F-91C2-4280-ADFE-6036ABE49365Q38694793-7D3548D1-1D98-4F1F-AC22-45E536845A25Q38738733-B493D7D5-6B01-4550-B097-1D25D72ACEC1
P2860
CXCR4/CXCL12 mediate autocrine cell- cycle progression in NF1-associated malignant peripheral nerve sheath tumors.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
CXCR4/CXCL12 mediate autocrine ...... eripheral nerve sheath tumors.
@ast
CXCR4/CXCL12 mediate autocrine ...... eripheral nerve sheath tumors.
@en
type
label
CXCR4/CXCL12 mediate autocrine ...... eripheral nerve sheath tumors.
@ast
CXCR4/CXCL12 mediate autocrine ...... eripheral nerve sheath tumors.
@en
prefLabel
CXCR4/CXCL12 mediate autocrine ...... eripheral nerve sheath tumors.
@ast
CXCR4/CXCL12 mediate autocrine ...... eripheral nerve sheath tumors.
@en
P2093
P2860
P1433
P1476
CXCR4/CXCL12 mediate autocrine ...... eripheral nerve sheath tumors.
@en
P2093
Amish Patel
Chad J Creighton
Liang Zhang
Luis F Parada
Renée M McKay
P2860
P304
P356
10.1016/J.CELL.2013.01.053
P407
P577
2013-02-21T00:00:00Z